Skin autofluorescence predicts incident type 2 diabetes, cardiovascular disease and mortality in the general population.
Robert P van WaateringeBernardina T FokkensSandra N SlagterMelanie M van der KlauwJana V van Vliet-OstaptchoukReindert GraaffAndrew D PatersonAndries J SmitHelen L LutgersBruce H R WolffenbuttelPublished in: Diabetologia (2018)
The non-invasive skin autofluorescence measurement is of clinical value for screening for future risk of type 2 diabetes, CVD and mortality, independent of glycaemic measures and the metabolic syndrome.